Update on the Diagnosis of Behcet's Disease

被引:26
|
作者
Alibaz-Oner, Fatma [1 ]
Direskeneli, Haner [1 ]
机构
[1] Marmara Univ, Sch Med, Dept Internal Med, Div Rheumatol, TR-34722 Istanbul, Turkiye
关键词
Behcet's disease; diagnosis; venous wall thickness; ultrasonography; GENOME-WIDE ASSOCIATION; VENOUS WALL THICKNESS; CLASSIFICATION CRITERIA; VASCULAR INVOLVEMENT; OUTCOME SURVEY; PATHERGY TEST; PERFORMANCE; HLA-B-ASTERISK-51; MORTALITY; SKIN;
D O I
10.3390/diagnostics13010041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease (BD) is a systemic inflammatory disease with unknown etiology. It is characterized by recurrent mucocutaneous lesions and major organ disease such as ocular, neurologic, vascular, and gastrointestinal manifestations. The diagnosis of BD is mainly based on clinical manifestations after ruling out other potential causes. There are no specific laboratory, histopathologic, or genetic findings for the diagnosis of BD. The International Study Group (ISG) criteria set is still the most widely used set for the diagnosis. The main limitation of this criteria set is the lack of major organ manifestations such as vascular, neurologic, and gastrointestinal involvement. The ICBD 2014 criteria are more sensitive, especially in early disease. However, patients with such as spondyloarthritis can easily meet this criteria set, causing overdiagnosis. Diagnosing BD can be a big challenge in daily practice, especially in patients presenting with only major organ involvement such as posterior uveitis, neurologic, vascular, and gastrointestinal findings with or without oral ulcers. These patients do not meet ISG criteria and can be diagnosed with "expert opinion" in countries with high BD prevalence. The pathergy test is the only diagnostic test used as diagnostic or classification criteria for BD. Our recent studies showed that common femoral vein (CFV) thickness measurement can be a valuable, practical, and cheap diagnostic tool for BD with sensitivity and specificities higher than 80% for the cut-off value of 0.5 mm. However, the diagnostic accuracy of CFV measurement should be investigated in other disease groups in the differential diagnosis of BD and in also different ethnic populations.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Osteonecrosis of Behcet's disease:: diagnosis, therapy, and course
    Jäger, M
    Thorey, F
    Wild, A
    Voede, M
    Krauspe, R
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2003, 62 (04): : 390 - 394
  • [32] Behcet's disease as a systemic disease
    Mat, M. Cem
    Sevim, Aysegul
    Fresko, Izzet
    Tuzun, Yalcin
    CLINICS IN DERMATOLOGY, 2014, 32 (03) : 435 - 442
  • [33] Myocardial involvement in Behcet's disease may be higher in patients with Neuro-Behcet's disease: a speckle tracking echocardiographic study
    Sunbul, Murat
    Midi, Ipek Gursoy
    Agackiran, Seda Kutlug
    Engin, Esin
    Ucem, Selen
    Alibaz-Oner, Fatma
    Sayar, Nurten
    Direskeneli, Haner
    Sadic, Beste Ozben
    ACTA CARDIOLOGICA, 2022, 77 (06) : 515 - 523
  • [34] Familial Behcet's disease
    Srivastava, Neerej
    Chand, Satish
    Bansal, Manish
    Srivastava, Kanchan
    Singh, Sanjay
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2007, 73 (04): : 260 - 261
  • [35] Cytokines and Behcet's Disease
    Zhou, Z. Y.
    Chen, S. L.
    Shen, N.
    Lu, Y.
    AUTOIMMUNITY REVIEWS, 2012, 11 (10) : 699 - 704
  • [36] Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
    Park Y.
    Cheon J.H.
    Current Gastroenterology Reports, 2020, 22 (5)
  • [37] Pathophysiology of Behcet's disease
    Houman, M. H.
    Feki, N. Bel
    REVUE DE MEDECINE INTERNE, 2014, 35 (02): : 90 - 96
  • [38] Primary Headache in Behcet's and Neuro-Behcet's Disease
    Beton, Ozlem Ergin
    Yucesan, Canan
    NEUROLOGY INDIA, 2022, 70 (01) : 254 - 257
  • [39] Behcet's disease in women
    Hamzaoui, A.
    Klii, R.
    Harzallah, O.
    Attig, C.
    Mahjoub, S.
    REVUE DE MEDECINE INTERNE, 2012, 33 (10): : 552 - 555
  • [40] Behcet's Disease in Children: Diagnostic and Management Challenges
    Costagliola, Giorgio
    Cappelli, Susanna
    Consolini, Rita
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 495 - 507